HutchMed aims to establish a bigger presence in the city when the first wet laboratories at the much larger Hong…
Read More »Cancer
Evive Biotech, a unit of Shenzhen-listed Yifan Pharmaceutical, aims to break the dominance of American drugs developer Amgen in the…
Read More »Hutchison China MediTech (Chi-Med), whose stock has surged 70 per cent in London over the past six months, expects to…
Read More »Three hospital systems across England have begun a live clinical trial of AI technology designed to detect and grade prostate…
Read More »A collaborative study has uncovered microproteins exclusive to liver tumors, presenting a new avenue for cancer vaccine development. These microproteins…
Read More »Dr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar…
Read More »In a major genetic study, over 5,000 variants linked to increased cancer risk were identified in the BAP1 gene, revealing…
Read More »Developed by MIT researchers, Leuko’s device offers a noninvasive method for cancer patients to monitor their immune health at home.…
Read More »A breakthrough treatment uses nutrient-based nanomedicine to reactivate dormant metabolic pathways in cancer cells, effectively stopping melanoma growth. This new…
Read More »Research at Georgia State University focusing on Ethiopian medicinal plants is showing potential in combating cervical cancer. Led by Professor…
Read More »